top of page

Publications

  1. Joannah R. Fergusson, Jacqueline H.Y. Siu, Nitya Gupta, Edward Jenkins, Eloise Nee, Sören Reinke, Tamara Ströbel, Ananya Bhalla, Shyami M. Kandage, Thomas Courant, Sarah Hill, Moustafa Attar, Michael L. Dustin, Alex Gordon-Weeks, Mark Coles, Calliope A. Dendrou, and Anita Milicic. Ex vivo model of functioning human lymph node reveals role for innate lymphocytes and stroma in response to vaccine adjuvant. doi: 10.1016/j.celrep.2025.115938 Cell Reports, 2025

  2. Romain Guyon, Sören Reinke, Adam Truby, Lee Sims, Adrian V. S. Hill, Luca Bau, Eleanor Stride, Anita Milicic. Core-shell microcapsules compatible with routine injection enable prime/boost immunization against malaria with a single shot. https://doi.org/10.1126/scitranslmed.adw2256

  3. Jacqueline HY Siu, Sofia Coelho, Aime Palomeras, Sandra Belij-Rammerstorfer, Chloe H Lee, Tamara Strobel, Christopher Thorpe, Charandeep Kaur, Tom Cole, Nico Remmert, Jamie Fowler, Sam Pledger, Kyla B Dooley, Daniel Opoka, Tamas Szommer, Samantha Vanderslott, Pontiano Kaleebu, Anita Milicic, Donald B Palmer, Teresa Lambe, Brian D Marsden, Hashem Koohey, Mark Coles, Calliope A Dendrou, Katrina M Pollock. Early regional lymph node activation drives influenza vaccine responses in an ancestrally diverse cohort. doi: https://doi.org/10.1101/2024.10.28.620725 Preprint 2024

  4. Reinke S, Pantazi E, Chappell GR, Sanchez-Martinez A, Guyon R, Fergusson JR, Salman AM, Aktar A, Mukhopadhyay E, Ventura RA, Auderset F, Dubois PM, Collin N, Hill AVS, Bezbradica JS*, Milicic A*. Emulsion and liposome-based adjuvanted R21 vaccine formulations mediate protection against malaria through distinct immune mechanisms. Cell Rep Med. 2023 Nov 21;4(11):101245. doi:10.1016/j.xcrm.2023.101245. Epub 2023 Oct 31. PMID: 37913775; PMCID:PMC10694591

  5. Codd AS, Hanna SJ, Compeer EB, Richter FC, Pring EJ, Gea-Mallorquí E, Borsa M, Moon OR, Scourfield DO; Oxford-Cardiff COVID-19 Literature Consortium; Gallimore AM, Milicic A. Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology. Oxf Open Immunol. 2021 Jul 15;2(1):iqab016. doi:10.1093/oxfimm/iqab016. PMID: 35593707; PMCID: PMC8371938.

  6. Scourfield DO, Reed SG, Quastel M, Alderson J, Bart VMT, Teijeira Crespo A, Jones R, Pring E, Richter FC; Milicic A (Oxford-Cardiff COVID-19 Literature Consortium); Burnell SEA. The role and uses of antibodies in COVID-19 infections: a living review. Oxf Open Immunol. 2021 Jan 28;2(1):iqab003. doi: 10.1093/oxfimm/iqab003. PMID: 34192270; PMCID: PMC7928637

  7. Luchner M, Reinke S, Milicic A. TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases. Pharmaceutics. 2021 Jan 22;13(2):142. doi: 10.3390/pharmaceutics13020142. PMID: 33499143; PMCID: PMC791162​

  8. Hanna SJ, Codd AS, Gea-Mallorqui E, Scourfield DO, Richter FC, Ladell K, Borsa M, Compeer EB, Moon OR, Galloway SAE, Dimonte S, Capitani L, Shepherd FR, Wilson JD, Uhl LFK; Oxford-Cardiff COVID-19 Literature Consortium; Gallimore AM, Milicic A. T cell phenotypes in COVID-19 - a living review. Oxf Open Immunol. 2020 Dec 29;2(1):iqaa007. doi: 10.1093/oxfimm/iqaa007. PMID: 33575657; PMCID: PMC7798577

  9. Reinke S, Thakur A, Gartlan C, Bezbradica JS, Milicic A. Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants. Vaccines (Basel). 2020 Sep 22;8(3):554. doi: 10.3390/vaccines8030554. PMID: 32971761; PMCID: PMC7565252​

  10. Lemoine C, Thakur A, Krajišnik D, Guyon R, Longet S, Razim A, Górska S, Pantelić I, Ilić T, Nikolić I, Lavelle EC, Gamian A, Savić S, Milicic A. Technological Approaches for Improving Vaccination Compliance and Coverage. Vaccines (Basel). 2020 Jun 16;8(2):304. doi: 10.3390/vaccines8020304. PMID:32560088; PMCID: PMC7350210.

  11. Sanders T 2nd, Milicic A, Stride E. Investigating the Effect of Encapsulation Processing Parameters on the Viability of Therapeutic Viruses in Electrospraying. Pharmaceutics. 2020 Apr 24;12(4):388. doi:10.3390/pharmaceutics12040388. PMID: 32344667; PMCID: PMC7238258.

  12. Elshina E, Allen ER, Flaxman A, van Diemen PM, Milicic A, Rollier CS, Yamaguchi Y, Wyllie DH. Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease. Vaccine. 2019 Jan 14;37(3):502-509. doi: 10.1016/j.vaccine.2018.11.036. Epub 2018 Nov 28. PMID: 30502067.

  13. Flaxman A, van Diemen PM, Yamaguchi Y, Allen E, Lindemann C, Rollier CS, Milicic A, Wyllie DH. Development of persistent gastrointestinal S. aureus carriage in mice. Sci Rep. 2017 Sep 29;7(1):12415. doi:10.1038/s41598-017-12576-0. PMID: 28963555; PMCID: PMC562207​

  14. Milicic A, Rollier CS, Tang CK, Longley R, Hill AVS, Reyes-Sandoval A. Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria. Sci Rep. 2017 Aug 4;7(1):7284. doi: 10.1038/s41598-017-07246-0. Erratum in: Sci Rep. 2019m May 3;9(1):7060. PMID: 28779101; PMCID: PMC5544665.

  15. ​Diemen PMV, Leneghan DB, Brian IJ, Miura K, Long CA, Milicic A, Biswas S, Rollier CS, Wyllie DH. The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens. Sci Rep. 2017 May 11;7(1):1745. doi: 10.1038/s41598-017-01421-z. PMID: 28496136; PMCID:PMC5431793.

  16. ​Walters AA, Krastev C, Hill AV, Milicic A. Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy. J Pharm Pharmacol. 2015 Mar;67(3):400-8. doi: 10.1111/jphp.12367. Epub 2015 Feb 2. PMID: 25644530.

  17. ​Sadeyen JR, Wu Z, Davies H, van Diemen PM, Milicic A, La Ragione RM, Kaiser P, Stevens MP, Dziva F. Immune responses associated with homologous protection conferred by commercial vaccines for control of avian pathogenic Escherichia coli in turkeys. Vet Res. 2015 Jan 23;46(1):5. doi: 10.1186/s13567-014-0132-5. PMID: 25613193; PMCID: PMC4304773.

  18. ​Warimwe GM, Lorenzo G, Lopez-Gil E, Reyes-Sandoval A, Cottingham MG, Spencer AJ, Collins KA, Dicks MD, Milicic A, Lall A, Furze J, Turner AV, Hill AV, Brun A, Gilbert SC. Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice. Virol J. 2013 Dec 5;10:349. doi:10.1186/1743-422X-10-349. PMID: 24304565; PMCID: PMC4235025.

  19. ​Reyes-Sandoval A, Rollier CS, Milicic A, Bauza K, Cottingham MG, Tang CK, Dicks MD, Wang D, Longley RJ, Wyllie DH, Hill AV. Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity. Mol Ther. 2012 Aug;20(8):1633-47. doi: 10.1038/mt.2012.25. Epub 2012 Feb PMID: 22354374; PMCID: PMC3412496.

  20. ​Antrobus RD, Lillie PJ, Berthoud TK, Spencer AJ, McLaren JE, Ladell K, Lambe T, Milicic A, Price DA, Hill AV, Gilbert SC. A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years. PLoS One. 2012;7(10):e48322. doi: 10.1371/journal.pone.0048322. Epub 2012 Oct 31. PMID: 23118984; PMCID: PMC3485192.

  21. ​Milicic A, Kaur R, Reyes-Sandoval A, Tang CK, Honeycutt J, Perrie Y, Hill AV. Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses. PLoS One. 2012;7(3):e34255. doi: 10.1371/journal.pone.0034255. Epub 2012 Mar 28. PMID:22470545; PMCID: PMC3314611.

  22. ​de Cassan SC, Forbes EK, Douglas AD, Milicic A, Singh B, Gupta P, Chauhan VS, Chitnis CE, Gilbert SC, Hill AV, Draper SJ. The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus. J Immunol. 2011 Sep 1;187(5):2602-16. doi: 10.4049/jimmunol.1101004. Epub 2011 Aug 3. PMID: 21813775; PMCID: PMC3160495.

  23. ​Reyes-Sandoval A, Wyllie DH, Bauza K, Milicic A, Forbes EK, Rollier CS, Hill AV. CD8+ T effector memory cells protect against liver-stage malaria. J Immunol. 2011 Aug 1;187(3):1347-57. doi: 10.4049/jimmunol.1100302. Epub 2011 Jun 29. PMID: 21715686; PMCID: PMC4568294.

  24. ​Berthoud TK, Hamill M, Lillie PJ, Hwenda L, Collins KA, Ewer KJ, Milicic A, Poyntz HC, Lambe T, Fletcher HA, Hill AV, Gilbert SC. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis. 2011 Jan 1;52(1):1-7. doi: 10.1093/cid/ciq015. PMID:21148512; PMCID: PMC3060888.

  25. ​Choudhuri K, Parker M, Milicic A, Cole DK, Shaw MK, Sewell AK, Stewart-Jones G, Dong T, Gould KG, van der Merwe PA. Peptide-major histocompatibility complex dimensions control proximal kinase-phosphatase balance during T cell activation. J Biol Chem. 2009 Sep 18;284(38):26096-105. doi: 10.1074/jbc.M109.039966. Epub 2009 Jul 23. PMID: 19628870; PMCID: PMC2758009.

  26. ​Varela-Rohena A, Molloy PE, Dunn SM, Li Y, Suhoski MM, Carroll RG, Milicic A, Mahon T, Sutton DH, Laugel B, Moysey R, Cameron BJ, Vuidepot A, Purbhoo MA, Cole DK, Phillips RE, June CH, Jakobsen BK, Sewell AK, Riley JL. Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat Med. 2008 Dec;14(12):1390-5. doi: 10.1038/nm.1779. Epub 2008 Nov 9. PMID: 18997777; PMCID: PMC3008216.

  27. ​Milicic A, Harrison LA, Goodlad RA, Hardy RG, Nicholson AM, Presz M, Sieber O, Santander S, Pringle JH, Mandir N, East P, Obszynska J, Sanders S, Piazuelo E, Shaw J, Harrison R, Tomlinson IP, McDonald SA, Wright NA, Jankowski JA. Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fission in vivo. Cancer Res. 2008 Oct 1;68(19):7760-8. doi: 10.1158/0008-5472.CAN-08-0020. PMID: 18829530; PMCID: PMC2561210.

  28. ​Laugel B, van den Berg HA, Gostick E, Cole DK, Wooldridge L, Boulter J, Milicic A, Price DA, Sewell AK. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J Biol Chem. 2007 Aug 17;282(33):23799-810. doi:10.1074/jbc.M700976200. Epub 2007 May 31. PMID: 17540778.

  29. ​Purbhoo MA, Li Y, Sutton DH, Brewer JE, Gostick E, Bossi G, Laugel B, Moysey R, Baston E, Liddy N, Cameron B, Bennett AD, Ashfield R, Milicic A, Price DA, Classon BJ, Sewell AK, Jakobsen BK. The HLA A*0201-restricted hTERT(540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor. Mol Cancer Ther. 2007 Jul;6(7):2081-91. doi:10.1158/1535-7163.MCT-07-0092. PMID: 17620437.

  30. ​Laugel B, Price DA, Milicic A, Sewell AK. CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functions. Eur J Immunol. 2007 Apr;37(4):905-13. doi:10.1002/eji.200636718. PMID: 17393387; PMCID: PMC2699424.

  31. ​Zimbwa P, Milicic A, Frater J, Scriba TJ, Willis A, Goulder PJ, Pillay T, Gunthard H, Weber JN, Zhang HT, Phillips RE. Precise identification of a human immunodeficiency virus type 1 antigen processing mutant. J Virol. 2007 Feb;81(4):2031-8. doi: 10.1128/JVI.00968-06. Epub 2006 Nov 15. PMID: 17108020; PMCID: PMC1797578.

  32. Wooldridge L, Scriba TJ, Milicic A, Laugel B, Gostick E, Price DA, Phillips RE, Sewell AK. Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers. Eur J Immunol. 2006 Jul;36(7):1847-55. doi: 10.1002/eji.200635886. PMID: 16783852.

  33. ​Milicic A, Edwards CT, Hué S, Fox J, Brown H, Pillay T, Drijfhout JW, Weber JN, Holmes EC, Fidler SJ, Zhang HT, Phillips RE. Sexual transmission of single human immunodeficiency virus type 1 virions encoding highly polymorphic multisite cytotoxic T-lymphocyte escape variants. J Virol. 2005 Nov;79(22):13953-62. doi: 10.1128/JVI.79.22.13953-13962.2005. PMID: 16254331; PMCID: PMC1280182.

  34. ​Milicic A, Price DA, Zimbwa P, Booth BL, Brown HL, Easterbrook PJ, Olsen K, Robinson N, Gileadi U, Sewell AK, Cerundolo V, Phillips RE. CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef. J Immunol. 2005 Oct 1;175(7):4618-26. doi: 10.4049/jimmunol.175.7.4618. PMID: 16177107.

  35. ​Wooldridge L, van den Berg HA, Glick M, Gostick E, Laugel B, Hutchinson SL, Milicic A, Brenchley JM, Douek DC, Price DA, Sewell AK. Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface. J Biol Chem. 2005 Jul 29;280(30):27491-501. doi: 10.1074/jbc.M500555200. Epub 2005 Apr 18. PMID: 15837791; PMCID: PMC2441837.

  36. ​Newton J, Brown MA, Milicic A, Ackerman H, Darke C, Wilson JN, Wordsworth BP, Kwiatkowski D. The effect of HLA-DR on susceptibility to rheumatoid arthritis is influenced by the associated lymphotoxin alpha-tumor necrosis factor haplotype. Arthritis Rheum. 2003 Jan;48(1):90-6. doi: 10.1002/art.10719. PMID: 12528108.

  37. ​Harney S, Newton J, Milicic A, Brown MA and Wordsworth BP. Non-inherited maternal HLA alleles are associated with rheumatoid arthritis.  Rheumatology. 2003 Jan;42(1)171-4.

  38. ​MacKay K, Milicic A, Lee D, Tickly M, Laval S, Shatford J and Wordsworth BP. Rheumatoid arthritis susceptibility and interleukin 10: a study of two ethnically diverse populations. Rheumatology. 2003 Jan;42(1)171-4.

  39. ​Milicic A, Misra R, Agrawal S, Aggarwal A, Brown MA, Wordsworth BP. The F158V polymorphism in FcgammaRIIIa shows disparate associations with rheumatoid arthritis in two genetically distinct populations. Annals of Rheumatic Diseases. 2002 Nov;61(11):1021-3.

  40. ​Milicic A, Lee D, Brown MA, Darke C, Wordsworth BP. HLA-DR/DQ haplotype in rheumatoid arthritis: novel allelic associations in UK Caucasians. J Rheumatol. 2002 Sep;29(9):1821-6. PMID: 12233873.

  41. ​MacKay K, Eyre S, Myerscough A, Milicic A, Barton A, Laval S, Barrett J, Lee D, White S, John S, Brown MA, Bell J, Silman A, Ollier W, Wordsworth P, Worthington J. Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum. 2002 Mar;46(3):632-9. doi: 10.1002/art.10147.

  42. ​Milicic A, Brown M, Wordsworth P. Polymorphism in codon 17 of the CTLA-4 gene (+49 A/G) is not associated with susceptibility to Rheumatoid Arthritis in British Caucasians. Tissue Antigens. 2001 Jul;58(1):50-4.

  43. ​Laval SH, Timms A, Edwards S, Bradbury L, Brophy S, Milicic A, Rubin L, Siminovitch KA, Weeks D, Calin A, Wordsworth BP, Brown MA. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. American Journal of Human Genetics. 2001 Apr;68(4):918-26.

  44. ​Milicic A, Lindheimer F, Laval S, Rudwaleit M, Ackerman H, Wordsworth P, Hohler T, Brown MA.  Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis. Genes and Immunity. 2000 Oct;1(7):418-22.

​

bottom of page